CellVec’s state-of-the-art GMP manufacturing facility, constructed based on the principles of the PIC/S GMP guide, Eudralex Vol. 4 and relevant annexes, encompasses the process-driven design approach that we adopt for the manufacture of viral vectors for gene therapy and other cellular ATMPs. Our GMP production Clean room facility is constructed to accommodate flexible Viral Vector production runs, where we focus on a single product at a time, on a campaign basis.